Patents by Inventor William Harold Donish

William Harold Donish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6645758
    Abstract: A cuvette and a method of use prevent nucleic acid amplified by PCR technology from being released to the atmosphere, while still proceeding to a detection step to determine whether or not the nucleic acid is present. Detection reagents are either pre-incorporated into compartments in the cuvette or added after amplification. In the latter case, a check valve prevents amplified nucleic acid from being released. Transfer of liquids between compartments is achieved via the use of flexible compartment walls and an external pressure source, or via pistons that are part of the cuvette and operate on the compartments as a piston within a piston chamber.
    Type: Grant
    Filed: September 28, 1992
    Date of Patent: November 11, 2003
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: Paul Nicholas Schnipelsky, Leonard Joseph Seaberg, Charles Cullis Hinckley, Jeffrey Allen Wellman, William Harold Donish, John Bruce Findlay
  • Patent number: 6475729
    Abstract: Nucleic acids can be amplified and detected using a very rapid polymerase chain reaction procedure. This procedure includes a series of steps which have critically defined temperature and time parameters. Each polymerase chain reaction cycle requires generally less than about two minutes, and in most cases less than 90 seconds. At least 5 units/100 &mgr;l of solution of thermostable DNA polymerase are used, and other preferred levels of primer concentrations facilitate the quick cycling in the amplification. In preferred embodiments, only two temperatures are used in the amplification.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: November 5, 2002
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: John Bruce Findley, John Wesley Backus, William Harold Donish, John William H. Sutherland
  • Patent number: 5888723
    Abstract: Nucleic acids can be amplified and detected using an element which has a sealable support on which is disposed a nucleic acid reagent composition. The composition is a mixture of a nucleic acid reagent composed of polymeric particles to which an oligonucleotide is covalently attached. The particles are prepared from a first polymer having a glass transition temperature of at least about 70.degree. C. and have an average diameter of from about 0.1 to about 3 micrometers. The reagent is adhered to the support using a water insoluble adhesive comprising a second polymer which has a glass transition temperature which is at least about 30.degree. C. less than the glass transition temperature of the first polymer. The adhesive is present in the composition at from about 1 to about 20 dry weight percent. The method provides high sensitivity and low background in the assay of nucleic acids, preferably using polymerase chain reaction.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: March 30, 1999
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: Richard Calvin Sutton, Ignazio Salvatore Ponticello, Thomas Joseph Cummins, Dennis Roland Zander, William Harold Donish, Paul Hong-Dze Chen, John Bruce Findlay
  • Patent number: 5674717
    Abstract: Nucleic acids can be amplified and detected using a very rapid polymerase chain reaction procedure in which two different nucleic acid sequences are present. This method allows one to preferentially modulate (for example, suppress) the degree of amplification of one or more nucleic acid sequences relative to other nucleic acid sequences. This modulation is achieved by exploiting differences in the relative primer melt temperatures, or by using certain ratios of primers. Each PCR cycle is very fast, that is less than about 90 seconds. This method is particularly useful for amplification and detection of DNA associated with infectious agents that may be present in a specimen in very small quantities compared to other nontargeted nucleic acids.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: October 7, 1997
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: John W. Backus, William Harold Donish, John Bruce Findlay, John William H. Sutherland, Marlene M. King